A field trial of DSM-III-R psychoactive substance dependence disorders.
A field trial of DSM-III-R psychoactive substance dependence disorders.
复制标题
DSM-III-R 精神活性物质依赖障碍的现场试验。
DOI：
10.1176/ajp.144.3.351
复制
发表时间：
1987
期刊：
影响因子：
--
通讯作者：
R. Spitzer
中科院分区：
文献类型：
--
作者：
B. Rounsaville;T. Kosten;J. Williams;R. Spitzer
作者现场测试了修订版DSM-III（DSM-III-R）中提出的精神活性物质使用障碍诊断标准，并在83例患者的治疗组中将其与DSM-III标准进行了比较。他们发现诊断系统在诊断率和接受诊断的个人之间存在高度一致性。当DSM-III-R诊断所需的最少症状数量设置为3时，发生了最大的跨系统一致性。系统之间的差异诊断与DSM-III-R诊断要求的社会后果相关，DSM-III-R对生理耐受性的强调较少，以及轻度症状受试者的分歧。
The authors field-tested proposed criteria for diagnoses of psychoactive substance use disorders in the revision of DSM-III (DSM-III-R) and compared them with DSM-III criteria in a treated group of 83 patients. They found a high level of agreement between the diagnostic systems in rates of diagnosis and in the individuals receiving the diagnosis. The greatest cross-system agreement occurred when the minimum number of symptoms required to make the DSM-III-R diagnosis was set at three. Discrepant diagnoses between systems related to removal of social consequences as a requirement for the DSM-III-R diagnoses, less emphasis on physiological tolerance in DSM-III-R, and disagreement in subjects with mild symptoms.